Abstract
The normal function of the cardiovascular system depends on several interrelated mechanisms working both in the cells of the vascular vessels (endothelial and vascular smooth muscle cells) and in elements such as blood cells and humoral factors present in the blood. Many of the cardiovascular diseases are initiated by alterations in the cells of the vascular wall, which by different etiologic factors (endothelial dysfunction, atherosclerosis) induce proliferation and apoptosis of both endothelial cells and vascular smooth muscle cells. This apoptotic process is controlled by a diversity of cell signalling events, which originate either outside or inside the cells. Extracellular signals include cytokines, hormones, growth factors or nitric oxide that cross the plasma membrane or transduce to effect a response. The intracellular activation of the apoptotic machinery can be initiated by any stressful message to the cell with a resultant cell suicide. In the following lines, we will review the most important mechanisms that regulate apoptosis in endothelial and smooth muscle cells.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Abstract
Anselmi A, Abbate A, Girola F et al. (2004) Myocardial ischemia, stunning, inflammation, and apoptosis during cardiac surgery: a review of evidence. Eur J Cardiothorac Surg 25:304ā311
Baldwin A (2001) The transcription factor NK-6B and human disease. J Clin Invest 107:3ā6
Berridge MJ (2008) Smooth muscle cell calcium activation mechanisms. J Physiol 586:5047ā5061
Blanco-Colio LM, HernĆ”ndez-Presa MA, Ortego M et al. (2000) Papel potencial de la apoptosis en la aterosclerosis. Cardiovasc Risk Fact 9:131ā137
Brookes PS, Salinas EP, Darley-Usmar K et al. (2000) Concentration-dependent effects of nitric oxide on mitochondrial permeability transition and cytochrome c release. J Biol Chem 275:20474ā20479
Brunt KR, Fenrich KK, Kiani G et al. (2006) Protection of human vascular smooth muscle cells from H2O2-induced apoptosis through functional codependence between HO-1 and AKT. Arterioscler Thromb Vasc Biol 26:2027ā2034
Buga GM, Gold ME, Fukuto JM et al. (1991) Shear stress-induced release of nitric oxide from endothelial cells grown on beads. Hypertension 17:187ā193
Burlacu A, Jinga VV, Gafencu AV et al. (2001) Severity of oxidative stress generates different mechanisms of endothelial cell death. Cell Tissue Res 306:409ā416
Buttery LD, Springall DR, Chester AH et al. (1996) Inducible nitric oxide synthase is present within human atherosclerotic lesions and promotes the formation and activity of peroxynitrite. Lab Invest 75:77ā85
Celermajer DS (1997) Endothelial dysfunction: does it matter? Is it reversible?. J Am Coll Cardiol 30:325ā333
Chen QM, Tu VC (2002) Apoptosis and Heart Failure: Mechanisms and Therapeutic Implications. Am J Cardiovasc Drugs 2:43ā57
Chung HT, Pae HO, Choi BM et al. (2001) Nitric oxide as a bioregulator of apoptosis. Biochem Biophys Res Commun 282:1075ā1079
Cines DB, Pollak ES, Buck CA et al. (1998) Endothelial cells in physiology and in the pathophysiology of vascular disorders. Blood 91:3527ā3561
Clarke M, Bennett M (2006) The emerging role of vascular smooth muscle cell apoptosis in atherosclerosis and plaque stability. Am J Nephrol 26:531ā535
Colucci WS (1996) Apoptosis in the heart. N Engl J Med 335:1224ā1226
Cooke JP, Tsao PS (1994) Is NO an endogenous antiatherogenic molecule? Arterioscler Thromb 14:753ā759
DĆez J (2000) Apoptosis en las enfermedades cardiovasculares. Rev Esp Cardiol 53:267ā274
Dimmeler S, Assmus B, Hermann C et al. (1998) Fluid shear stress stimulates phosphorylation of Akt in human endothelial cells: involvement in suppression of apoptosis. Circ Res 83:334ā341
Dimmeler S, Fleming I, Fisslthaler B et al. (1999) Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation. Nature 399:601ā605
Dimmeler S, Haendeler J, Galle J et al. (1997) Oxidized low-density lipoprotein induces apoptosis of human endothelial cells by activation of CPP32-like proteases. A mechanistic clue to the āresponse to injuryā hypothesis. Circulation 95:1760ā1763
Esper RJ, Nordaby RA, VilariƱo JO et al. (2006) Endothelial dysfunction: a comprehensive appraisal. Cardiovasc Diabetol 5:4ā18
Feletou M, Vanhoutte PM (1988) Endothelium-dependent hyperpolarization of canine coronary smooth muscle. Br J Pharmacol 93:515ā524
FortuƱo MA, Ravassa S, FortuƱo A et al. (2001) Cardiomyocyte apoptotic cell death in arterial hypertension: mechanisms and potential management. Hypertension 38:1406ā1412
Furchgott RF, Zawadzki JV (1980) The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 288:373ā376
Garland CJ, Plane F, Kemp BK et al. (1995) Endothelium-dependent hyperpolarization: a role in the control of vascular tone. Trends Biol Sci 16:23ā30
Geng YJ, Henderson LE, Levesque EB et al. (1997) Fas is expressed in human atherosclerotic intima and promotes apoptosis of cytokine-primed human vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 17:2200ā2208
Geng YJ, Wu Q, Muszynski M et al. (1996) Apoptosis of vascular smooth muscle cells induced by in vitro stimulation with interferon-gamma, tumor necrosis factor-alpha, and interleukin-1 beta. Arterioscler Thromb Vasc Biol 16:19ā27
Gordon D, Reidy MA, Benditt EP et al. (1990) Cell proliferation in human coronary arteries. Proc Natl Acad Sci USA 87:4600ā4604
Hamet P (1995) Proliferation and apoptosis in hypertension. Curr Opin Nephrol Hypertens 4:1ā7
Hamet P, Richard L, Dam T-H et al. (1995) Apoptosis in target organs of hypertension. Hypertension 26:642ā648
Hata S, Fukuo K, Morimoto S et al. (2001) Vascular smooth muscle maintains the levels of Bcl-2 in endothelial cells. Atherosclerosis 154:309ā316
IƱiguez MA, Cacheiro-Llaguno C, Cuesta N et al. (2008) Prostanoid function and cardiovascular disease. Arch Physiol Biochem 114:201ā209
James TN (1994) Normal and abnormal consequences of apoptosis in the human heart. From postnatal morphogenesis to paroxysmal arrhythmias. Circulation 90:556ā573
James TN, St Martin E, Willis PW et al. (1996) Apoptosis as a possible cause of gradual development of complete heart block and fatal arrthythmias asociated with absence of the AV node, sinus node, and internodal pathways. Circulation 93:1424ā1438
Johnston CJ (1992) Renin-angiotensin system: a dual tissue and hormonal system for cardiovascular control. J Cardiovasc Pharmacol 20(Suppl B):S1āS5
Jovinge S, Crisby M, Thyberg J, et al. (1997) DNA fragmentation and ultrastructural changes of degenerating cells in atherosclerotic lesions and smooth muscle cells exposed to oxidized LDL in vitro. Arterioscler Thromb Vasc Biol 17:2225ā2231
Kawano H, Do YS, Kawano Y et al. (2000) Angiotensin II has multiple profibrotic effects in human cardiac fibroblast. Circulation 101:1130ā1137
Kerr JF, Wyllie AH, Currie AR (1972) Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 26:239ā257
Kim YM, Bombeck CA, Billiar TR (1999) Nitric oxide as a bifunctional regulator of apoptosis. Circ Res 84:253ā256
Kockx MM, Herman AG (2000) Apoptosis in atherosclerosis: beneficial or detrimental? Cardiovasc Res 45:736ā746
Levin ER (1996) Endothelins as cardiovascular peptides. Am J Nephrol 16:246ā251
Libby P (1995) The molecular bases of the acute coronary syndromes. Circulation 91:2844ā2850
Littlewood TD, Bennett MR (2005) Apoptotic cell death in atherosclerosis. Curr Opin Lipidol 14:469ā475
Loscalzo J, Welch G (1995) Nitric oxide and its role in the cardiovascular system. Prog Cardiovasc Dis 38:87ā104
Madesh M, Hajnoczky G (2001) VDAC-dependent permeabilization of the outer mitochondrial membrane by superoxide induces rapid and massive cytochrome c release. J Cell Biol 155:1003ā1015
Messmer UK, Ankarcrona M, Nicotera P et al. (1994) p53 expression in nitric oxide-induced apoptosis. FEBS Lett 355:23ā26
Moon C, Krawczyk M, Ahn D et al. (2005) Erythropoietin reduces myocardial infarction and left ventricular functional decline after coronary artery ligation in rats. Proc Natl Acad Sci USA 100:11612ā11617
Olivetti G, Abbi R, Quaini F et al. (1997) Apoptosis in the failing human heart. N Engl J Med 336:1131ā1141
Overgaard CB, DzavĆk V (2008) Inotropes and vasopressors: review of physiology and clinical use in cardiovascular disease. Circulation 118:1047ā1056
Pacher P, Beckman JS, Liaudet L (2007) Nitric oxide and peroxynitrite in health and disease. Physiol Rev 87:315ā424
Papaharalambus CA, Griendling KK (2007) Basic mechanisms of oxidative stress and reactive oxygen species in cardiovascular injury. Trends Cardiovasc Med 17:48ā54
Parratt JR (1997) Nitric oxide. A key mediator in sepsis and endotoxaemia? J Physiol Pharmacol 48:493ā506
Parsa CJ, Matsumoto A, Kim J et al. (2005) A novel protective effect of erythropoietin in the infarcted heart. J Clin Invest 112:999ā1007
Pollman MJ, Hall JL, Gibbons GH (1999) Determinants of vascular smooth muscle cell apoptosis after balloon angioplasty injury. Influence of redox state and cell phenotype. Circ Res 84:113ā121
Raffetto JD, Leverkus M, Park H-Y et al. (2001) Synopsis on cellular senescence and apoptosis. J Vasc Surg 34:173ā177
Rajavashisth TB, Liao JK, Galis ZS et al. (1999) Inflammatory cytokines and oxidized low density lipoproteins increase endothelial cell expression of membrane type 1-matrix metalloproteinase. J Biol Chem 274:11924ā11929
Reed JC (2000) Mechanisms of apoptosis. Am J Pathol 157:1415ā1430
Rossig L, Dimmeler S, Zeiher AM (2001) Apoptosis in the vascular wall and atherosclerosis. Basic Res Cardiol 96:11ā22
Salas MA (2001) Apoptosis en el sistema cardiovascular: Un camino hacia nuevas estrategias terapĆ©uticas. Rev Fed Arg Cardiol 30:523ā532
Sanders KM, Ward SM (1992) Nitric oxide as a mediator of nonadrenergic noncholinergic neurotransmission. Am J Physiol Gastrointest Liver Physiol 262:G379āG392
Shichiri M, Yokokura M, Marumo F et al. (2000) Endothelin-1 inhibits apoptosis of vascular smooth muscle cells induced by nitric oxide and serum deprivation via MAP kinase pathway. Arterioscler Thromb Vasc Biol 20:989ā997
Simionescu M (2007) Implications of early structural-functional changes in the endothelium for vascular disease. Arterioscler Thromb Vasc Biol 27:266ā274
Snyder SH (1992) Nitric oxide: first in a new class of neurotransmitters. Science 257:494ā496
Stamler JS, Singel DJ, Loscalzo J (1992) Biochemistry of nitric oxide and its redox-activated forms. Science 258:1898ā1902
Stoneman VEA, Bennett MR (2004) Role of apoptosis in atherosclerosis and its therapeutic implications. Clinical Sci 107:343ā354
Tzeng E, Kim YM, Pitt BR et al. (1997) Adenoviral transfer of the inducible nitric oxide synthase gene blocks endothelial cell apoptosis. Surgery 122:255ā263
Voetsch B, Jin RC, Loscalzo L (2004) Nitric oxide insufficiency and atherothrombosis. Histochem Cell Biol 122:353ā367
Webb RC (2005) Smooth muscle contraction and relaxation. Advan Physiol Edu 27:201ā206
Xia Z, Liu M, Wu Y, Sharma V et al. (2006) N-acetylcysteine attenuates TNF-alpha-induced human vascular endothelial cell apoptosis and restores eNOS expression. Eur J Pharmacol 550:134ā142
Zhang W, Li D, Mehta JL (2004) Role of AIF in human coronary artery endothelial cell apoptosis. Am J Physiol Heart Circ Physiol 286:H354āH358
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
Ā© 2009 Springer Science+Business Media B.V.
About this chapter
Cite this chapter
Garcia-EstaƱ, J., Atucha, N. (2009). Apoptotic Events in Endothelial and Smooth Muscle Cells. In: Salido, G.M., Rosado, J.A. (eds) Apoptosis: Involvement of Oxidative Stress and Intracellular Ca2+ Homeostasi. Springer, Dordrecht. https://doi.org/10.1007/978-1-4020-9873-4_7
Download citation
DOI: https://doi.org/10.1007/978-1-4020-9873-4_7
Publisher Name: Springer, Dordrecht
Print ISBN: 978-1-4020-9872-7
Online ISBN: 978-1-4020-9873-4
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)